HER2 testing by immunohistochemistry in breast cancer: A multicenter proficiency ring study

Background: Human epidermal growth factor receptor 2 (HER2) over-expression in breast cancer is associated with aggressive tumor behavior and predicts response to targeted therapy. Accurate HER2 result is paramount for optimal patient management. However, routine HER2 immunohistochemistry (IHC) test...

Full description

Saved in:
Bibliographic Details
Main Authors: Md Pauzi, S.H., Masir, N., Yahaya, A., Mohammed, F., Tizen Laim, N.M.S., Mustangin, M., Aizudin, A.N., Talib, A., Teoh, K.-H., Karim, N., Oy-Leng, J.W., Rajadurai, P.
Format: Article
Published: Wolters Kluwer Medknow Publications 2021
Subjects:
Online Access:http://eprints.um.edu.my/35637/
Tags: Add Tag
No Tags, Be the first to tag this record!